The vote came as NIH looks to transition at least one of seven national primate research centers into an animal sanctuary.

FDA inspectors found a live spider and dead cricket in a facility that was compounding weight loss drugs for Hims & Hers.

The Food and Drug Administration has rejected a rare-disease gene therapy from Regenxbio, the company said Monday.

This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here. Speed skating is an elite Olympic ...

Today, we get news of the pressures facing Hims & Hers: Not only is Novo Nordisk suing the telehealth titan, but the government is putting it under scrutiny as well.

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-too-familiar ...

Novo's chief counsel says telehealth companies and compounding pharmacies that are continuing to make copycat versions of ...

President Trump claims that the administration’s new TrumpRx website will offer the cheapest prices in the world for 43 brand ...

Aerska, a startup developing treatments to silence the problematic genes that cause various brain diseases, has raised $39 ...

Novo Nordisk filed a lawsuit accusing Hims & Hers of infringing on a key patent for its widely sold Wegovy weight loss ...

Eli Lilly to buy Orna Therapeutics, which focuses on ‘in vivo’ CAR-T for autoimmune diseases, for $2.4 billion ...